Second Line Capital’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-50,381
Closed -$1.22M 159
2025
Q1
$1.22M Buy
50,381
+870
+2% +$21K 0.31% 49
2024
Q4
$1.99M Buy
49,511
+11,393
+30% +$458K 0.54% 41
2024
Q3
$2.41M Buy
38,118
+9,699
+34% +$614K 0.66% 34
2024
Q2
$1.51M Buy
+28,419
New +$1.51M 0.46% 46